Dr. Charles Bennett to Speak about Fluoroquinolones at PharmedOut’s June 2015 Conference

Charles Bennett MD PhD Chair of the Center for Economic Excellence in Medication Safety and Efficacy, Bennett-flashUniversity of South Carolina will be speaking at the PharmedOut’s 5th Annual Conference on June 11-12, 2015 at Georgetown University about Fluoroquinolones..

Fluoroquinolone Academic Research Update – Dr. Beatrice Golomb UCSD

Our FQ team will be working closely with Dr. Golomb as she takes research to the next level in the near future. Stay tuned here as I will be sure to inform the FQ community of any pertinent developments with her, along with developments with other researchers that we work with.

Nurse Practitioners, Not For Me

I would have to say that we are one of the most complex subset of patients that can be seen by a physician. More often than not, we often leave the average physician scratching his head as to how to diagnose or treat our condition. Keeping that context in mind, I have determined that I will never see another nurse practitioner again.

What is a Delayed Adverse Reaction?

If the patient never connects the dots he/she may never uncover what the root cause of his/her mysterious illness is, or are given a default diagnosis that is a "catch all" for the medical community. Considering the day and age that we live in, it is one of the greatest medical travesties, that is of monumental proportions, that is continually being perpetrated on innocent individuals.

The Semmelweis Effect

The Semmelweis effect takes place when a credible, articulate, intelligence patient presents a plausible mechanism for their medical problem, in the absence of any irrefutable diagnosis, and is dismissed by the medical establishment.